Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium

Breast Cancer Research and Treatment
Mia M GaudetPeter Kraft

Abstract

Current use of menopausal hormone therapy (MHT) has important implications for postmenopausal breast cancer risk, and observed associations might be modified by known breast cancer susceptibility loci. To provide the most comprehensive assessment of interactions of prospectively collected data on MHT and 17 confirmed susceptibility loci with invasive breast cancer risk, a nested case-control design among eight cohorts within the NCI Breast and Prostate Cancer Cohort Consortium was used. Based on data from 13,304 cases and 15,622 controls, multivariable-adjusted logistic regression analyses were used to estimate odds ratios (OR) and 95 % confidence intervals (CI). Effect modification of current and past use was evaluated on the multiplicative scale. P values <1.5 × 10(-3) were considered statistically significant. The strongest evidence of effect modification was observed for current MHT by 9q31-rs865686. Compared to never users of MHT with the rs865686 GG genotype, the association between current MHT use and breast cancer risk for the TT genotype (OR 1.79, 95 % CI 1.43-2.24; P interaction = 1.2 × 10(-4)) was less than expected on the multiplicative scale. There are no biological implications of the sub-multiplicative interactio...Continue Reading

References

Mar 1, 2000·American Journal of Epidemiology·L N KolonelF S Nagamine
Mar 16, 2000·Journal of Women's Health & Gender-based Medicine·K M RexrodeJ E Buring
Feb 15, 2001·JAMA : the Journal of the American Medical Association·S A Smith-WarnerD J Hunter
Feb 24, 2001·Controlled Clinical Trials·R B HayesUNKNOWN Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
May 3, 2005·Nature Reviews. Cancer·Graham A Colditz, Susan E Hankinson
Dec 13, 2005·Nature Reviews. Cancer·D J HunterUNKNOWN National Cancer Institute Breast and Prostate Cancer Cohort Consortium
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jun 5, 2008·European Journal of Human Genetics : EJHG·Astrid DempfleHelmut Schäfer
Mar 31, 2009·Nature Genetics·Shahana AhmedDouglas F Easton
Jul 8, 2009·International Journal of Cancer. Journal International Du Cancer·Takakazu KawaseKazuo Tajima
Oct 29, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ross L PrenticeDennis G Ballinger
May 11, 2010·Nature Genetics·Clare TurnbullDouglas F Easton
Oct 21, 2010·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Jan 26, 2011·Journal of the National Cancer Institute·Olivia FletcherJulian Peto
Jul 28, 2011·Journal of the National Cancer Institute·Daniele CampaFederico Canzian
Mar 20, 2012·Journal of the National Cancer Institute·Rowan T Chlebowski, Garnet L Anderson
Aug 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Helen WarrenIsabel dos-Santos-Silva
Oct 2, 2013·Endocrine-related Cancer·Anja RudolphUNKNOWN Breast Cancer Association Consortium
Jul 9, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Merete Ellingjord-DaleGiske Ursin
Nov 8, 2014·Journal of the National Cancer Institute·Judith S BrandKamila Czene

❮ Previous
Next ❯

Citations

Jun 24, 2017·International Journal of Epidemiology·R L MilneG G Giles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.